A first case report of HIV negative Kaposi's sarcoma treatment with liposomal doxorubicin hydrochloride in Japan

DOI 13 References
  • HAYASHI Shujiro
    Department of Dermatology, Dokkyo Medical University, School of Medicine
  • KAMINAGA Tomoko
    Department of Dermatology, Dokkyo Medical University, School of Medicine
  • KOIKE Masami
    Department of Dermatology, Dokkyo Medical University, School of Medicine
  • KURAMOCHI Masumi
    Department of Dermatology, Dokkyo Medical University, School of Medicine
  • OZAWA Yumi
    Department of Dermatology, Dokkyo Medical University, School of Medicine
  • ODA Sachiko
    Department of Dermatology, Dokkyo Medical University, School of Medicine
  • HAMASAKI Yoichiro
    Department of Dermatology, Dokkyo Medical University, School of Medicine
  • HATAMOCHI Atsushi
    Department of Dermatology, Dokkyo Medical University, School of Medicine

Bibliographic Information

Other Title
  • リポソーム化ドキソルビシン塩酸塩が奏功したHIV陰性カポジ肉腫の1例

Search this article

Abstract

The patient was a 70-years-old Peruvian woman whose HIV antibody was negative. She immigrated to Japan 15 years ago. The patient had prednisone therapy due to erythema nodosum and then she was referred to our department due to multiple purple spots and nodules developing from edema of both legs. Skin biopsy specimens were obtained from the nodules. The histopathologic findings included abnormally proliferated and dilated vessels, vascular slits, numerous red blood cells, and spindle-shaped cells in the dermis. PCR examination by using skin tissue was positive for the specific band of HHV-8. The patient received treatment with liposomal doxorubicin hydrochloride (Doxil) at a dose of 20 mg/m2 intravenously every 3 weeks for six cycles. HIV negative Kaposi sarcoma is particularly rare in Japan, because of the very small population ratios of HHP8-positive in Japanese. Liposomal doxorubicin hydrochloride is usually used in disseminated HIV-related Kaposi's sarcoma, while there have still been no reports of cases of Doxil for HIV negative Kaposi's sarcoma in Japan. We first report the HIV negative Kaposi's sarcoma treatment with Doxil with good tolerance and remission of the lesion. [Skin Cancer (Japan) 2015 ; 30 : 10-15]

Journal

  • Skin Cancer

    Skin Cancer 30 (1), 10-15, 2015

    The Japanese Skin Cancer Society

References(13)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top